With deep industry knowledge in the regulatory field, strengths of Noerr‘s healthcare practice include M&A and sales at the German and international scale, ongoing corporate advice to healthcare providers, and the IP and licensing elements of co-operation agreements. Evelyn Schulz has broad regulatory experience, covering areas such as cannabis, product compliance, and tele-health, and Isabel Jakobs assists in both transactions and in product liability disputes concerning medical devices.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'The Noerr team led by Isabel Jakobs stands out for its exceptional blend of legal precision, commercial pragmatism, and responsiveness. What makes this practice unique is its deep specialisation in regulatory and administrative law.'
Key clients
- Arthrex Inc.
- ANI Pharmaceuticals
- Bevaplast B.V.
- Dieter Schwarz Stiftung gGmbH
- Hamburger Konzernholding HGV (Hamburger Gesellschaft für Vermögens- und Beteiligungsmanagement)
- Hera Residenzen Pflege GmbH
- New Flag GmbH
- Monacum Partners
- Scandinavian Tobacco Group
- Straumann Group
- Stada Arzneimittel AG
- VIA equity Fund V K/S
Work highlights
Advised Arthrec Inc. in multijurisdictional patent infringement litigation, including at the Unified Patent Court (UPC) in a case concerning surgical sutures.
Advised HGV on the repurchase of the former municipal care facility PFLEGEN & WOHNEN HAMBURG GmbH (P&W).
Advising Scandinavian Tobacco Group on a strategic acquisition, including regulatory due diligence on various tobacco products of the target company
Practice head
Evelyn Schulz
Other key lawyers
Isabel Jakobs